MedPath
NMPA Approval

Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol

国药准字HJ20200012

December 13, 2024

H20200012

Drug Information

格隆溴铵福莫特罗吸入气雾剂

气雾剂

每罐120揿,每揿含格隆铵7.2μg与富马酸福莫特罗(以(C₁₉H₂₄N₂O₄)₂·C₄H₄O₄·2H₂O计)5.0μg

化学药品

December 13, 2024

December 12, 2029

Company Information

Applicant Company

ASTRAZENECA AB

SE-151 85 Södertälje, Sweden

Manufacturing Company

bespak hc limited

London Road, Holmes Chapel, Crewe, CW4 8BE, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

格隆溴铵福莫特罗吸入气雾剂 - NMPA 批准文号 | MedPath